Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update
Globe Newswire•05/08/2026•16:28 ET
0
Whiz Insights
– LOQTORZI(®) net revenue of $13.6 million in Q2 2026, up 15% over Q1 –
– Clinical data continue to mature across programs with emerging evidence of activity with tagmokitug in head and neck cancer –
Get started
Create a free account to read the full story.